Literature DB >> 8865321

Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers.

S Okumura1, Y Fukuda, K Takahashi, T Fujita, A Yamamoto, S Muranishi.   

Abstract

PURPOSE: The permeability of drugs across the Xenopus pulmonary membrane and the effects of various absorption enhancers on their absorption were examined using an in vitro Ussing chamber technique.
METHODS: Phenol red and fluorescein isothiocyanate-labeled dextrans (FDs) with different molecular weights were chosen as water-soluble model drugs. Absorption enhancers used in this study were N-lauryl-beta-D-maltopyranoside (LM), linoleic acid-HC060 mixed micelle (MM), sodium glycocholate (Na-GC), sodium caprate (Na-Cap), sodium salicylate (Na-Sal) and disodium EDTA (EDTA).
RESULTS: The permeability of drugs gradually decreased with increasing their molecular weights, and the absorption of phenol red significantly increased by these absorption enhancers. Among these additives, LM, MM and Na-Cap appeared to be more effective for enhancing the permeability of drugs than the others. Furthermore, we plotted the logarithm of apparent permeability coefficient (Papp) of these drugs against the logarithm of their molecular weights. There exists a good correlation between these parameters. We measured transmembrane resistance(Rm) of Xenopus pulmonary membrane during the transport experiment to examine the membrane integrity. The average Rm value was about 700 omega.cm2, and this value was maintained for 3 hr.
CONCLUSIONS: This method is useful for estimating the transport characteristics of drugs across the pulmonary membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865321     DOI: 10.1023/a:1016080723968

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

Review 1.  Absorption enhancers.

Authors:  S Muranishi
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1990       Impact factor: 4.889

2.  The pneumonocytes in the lung of Xenopus laevis.

Authors:  C Meban
Journal:  J Anat       Date:  1973-02       Impact factor: 2.610

3.  Absorption of saccharides and urea from the rat lung.

Authors:  S J Enna; L S Schanker
Journal:  Am J Physiol       Date:  1972-02

4.  Intestinal absorption enhanced by unsaturated fatty acids: inhibitory effect of sulfhydryl modifiers.

Authors:  M Murakami; K Takada; T Fujii; S Muranishi
Journal:  Biochim Biophys Acta       Date:  1988-04-07

5.  Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights.

Authors:  T Morita; A Yamamoto; M Hashida; H Sezaki
Journal:  Biol Pharm Bull       Date:  1993-03       Impact factor: 2.233

6.  Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors.

Authors:  Y Fukuda; T Tsuji; T Fujita; A Yamamoto; S Muranishi
Journal:  Biol Pharm Bull       Date:  1995-06       Impact factor: 2.233

7.  Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.

Authors:  T Morita; A Yamamoto; Y Takakura; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

8.  Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.

Authors:  M Tomita; M Hayashi; S Awazu
Journal:  J Pharmacol Exp Ther       Date:  1995-02       Impact factor: 4.030

9.  Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats.

Authors:  A Yamamoto; S Umemori; S Muranishi
Journal:  J Pharm Pharmacol       Date:  1994-01       Impact factor: 3.765

  9 in total
  1 in total

1.  Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery.

Authors:  Xiaoyu Chen; Wenhua Huang; Blenda Chi Wong; Linlin Yin; Yuen Fan Wong; Min Xu; Zhijun Yang
Journal:  Int J Nanomedicine       Date:  2012-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.